SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001753926-23-000649
Filing Date
2023-05-12
Accepted
2023-05-12 17:12:16
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q g083510_10q.htm   iXBRL 10-Q 513600
2 EXHIBIT 31.1 g083510_ex31-1.htm EX-31.1 14429
3 EXHIBIT 31.2 g083510_ex31-2.htm EX-31.2 14364
4 EXHIBIT 32.1 g083510_ex32-1.htm EX-32.1 5079
5 EXHIBIT 32.2 g083510_ex32-2.htm EX-32.2 4877
  Complete submission text file 0001753926-23-000649.txt   3489488

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lipo-20230331.xsd EX-101.SCH 34448
7 XBRL CALCULATION FILE lipo-20230331_cal.xml EX-101.CAL 39725
8 XBRL DEFINITION FILE lipo-20230331_def.xml EX-101.DEF 91630
9 XBRL LABEL FILE lipo-20230331_lab.xml EX-101.LAB 271036
10 XBRL PRESENTATION FILE lipo-20230331_pre.xml EX-101.PRE 202171
57 EXTRACTED XBRL INSTANCE DOCUMENT g083510_10q_htm.xml XML 409819
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41575 | Film No.: 23916984
SIC: 2834 Pharmaceutical Preparations